» Articles » PMID: 18430102

Minimally Invasive Esophagectomy: a Teaching Hospital's First Year Experience

Overview
Journal Dis Esophagus
Specialty Gastroenterology
Date 2008 Apr 24
PMID 18430102
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Surgical resection of the esophagus remains the mainstay of treatment for esophageal cancer. However, esophagectomy is associated with significant morbidity and mortality in the postoperative period. We have recently altered our practice pattern to include minimally invasive esophagectomy (MIE) as the approach of choice in the hope of minimizing morbidity associated with this procedure. In this retrospective analysis, we compare outcomes of our first year performing MIE to the previous 3 years of open esophagectomy (OE) at a single teaching hospital. Sixty-five patients underwent esophagectomy between June 2002 and July 2006. Among these, 22 patients underwent MIE between June 2005 and July 2006 and 43 patients underwent OE. The two groups were comparable with regards to age, comorbidities and pathologic stage. The MIE group had less operative blood loss (178 mL vs. 356 mL), decreased respiratory complications requiring mechanical ventila-tion (5% vs. 23%), increased number of lymph nodes procured per procedure (15 vs. 8), and increased number of patients discharged within 10 days (72% vs. 28%) when compared to the OE group. No difference was identified in mortality, complications, or length of stay.

Citing Articles

Advantages of McKeown minimally invasive oesophagectomy for the treatment of oesophageal cancer: propensity score matching analysis of 169 cases.

Xie J, Zhang L, Liu Z, Lu C, Xu G, Guo M World J Surg Oncol. 2022; 20(1):52.

PMID: 35216598 PMC: 8881864. DOI: 10.1186/s12957-022-02527-z.


Minimally invasive oesophagectomy: The first case report of a thoracolaparoscopic oesophagectomy done in the Caribbean.

Singh Y, Hosein A, Mohammed S, Kuruvilla T, Naraynsingh V Int J Surg Case Rep. 2020; 76:497-500.

PMID: 33207418 PMC: 7591550. DOI: 10.1016/j.ijscr.2020.10.055.


Minimally invasive esophagectomy is a safe surgical treatment for locally advanced pathologic T3 esophageal squamous cell carcinoma.

Zhang X, Yang Y, Ye B, Sun Y, Guo X, Hua R J Thorac Dis. 2017; 9(9):2982-2991.

PMID: 29221271 PMC: 5708425. DOI: 10.21037/jtd.2017.07.101.


Emergent Minimally Invasive Esophagogastrectomy.

Fabian T, Chiaravalle D, Martin J Case Rep Surg. 2017; 2017:4308628.

PMID: 28465855 PMC: 5390563. DOI: 10.1155/2017/4308628.


Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis.

Yibulayin W, Abulizi S, Lv H, Sun W World J Surg Oncol. 2016; 14(1):304.

PMID: 27927246 PMC: 5143462. DOI: 10.1186/s12957-016-1062-7.